326 related articles for article (PubMed ID: 8297698)
1. Medium-term follow up of residual shunting and potential complications after transcatheter occlusion of the ductus arteriosus.
Magee AG; Stumper O; Burns JE; Godman MJ
Br Heart J; 1994 Jan; 71(1):63-9. PubMed ID: 8297698
[TBL] [Abstract][Full Text] [Related]
2. Experience with 205 procedures of transcatheter closure of ductus arteriosus in 182 patients, with special reference to residual shunts and long-term follow-up.
Ali Khan MA; al Yousef S; Mullins CE; Sawyer W
J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1721-7. PubMed ID: 1341428
[TBL] [Abstract][Full Text] [Related]
3. Protrusion of the device: a complication of catheter closure of patent ductus arteriosus.
Ottenkamp J; Hess J; Talsma MD; Buis-Liem TN
Br Heart J; 1992 Sep; 68(3):301-3. PubMed ID: 1389763
[TBL] [Abstract][Full Text] [Related]
4. [Advances in interventional occlusion of persistent ductus arteriosus: comparison of results using different occlusion devices].
Koch A; Hofbeck M; Buheitel G; Gerling S; Rauch R; Singer H
Z Kardiol; 2001 Feb; 90(2):120-6. PubMed ID: 11263001
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of the patent ductus arteriosus: a comparative study between occluding coils and the Rashkind umbrella device.
Bulbul ZR; Fahey JT; Doyle TP; Hijazi ZM; Hellenbrand WE
Cathet Cardiovasc Diagn; 1996 Dec; 39(4):355-63; discussion 364. PubMed ID: 8958423
[TBL] [Abstract][Full Text] [Related]
6. Reocclusion for persistent shunting after catheter placement of the Rashkind patent ductus arteriosus occluder.
Hosking MC; Benson LN; Musewe N; Freedom RM
Can J Cardiol; 1989 Oct; 5(7):340-2. PubMed ID: 2531029
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter management of residual shunts after initial transcatheter closure of a patent arterial duct.
Ovaert C; McCrindle BW; Nykanen D; Freedom RM; Benson LN
Can J Cardiol; 2003 Dec; 19(13):1493-7. PubMed ID: 14760439
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter occlusion of patent ductus arteriosus by Rashkind umbrella device: follow-up results.
Arora R; Kalra GS; Nigam M; Khalillulah M
Am Heart J; 1994 Sep; 128(3):539-41. PubMed ID: 8074017
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of a large patent ductus arteriosus with the clamshell septal umbrella.
Bridges ND; Perry SB; Parness I; Keane JF; Lock JE
J Am Coll Cardiol; 1991 Nov; 18(5):1297-302. PubMed ID: 1918707
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting.
Hosking MC; Benson LN; Musewe N; Dyck JD; Freedom RM
Circulation; 1991 Dec; 84(6):2313-7. PubMed ID: 1959187
[TBL] [Abstract][Full Text] [Related]
11. Use of a second transcatheter Rashkind arterial duct occluder for persistent flow after implantation of the first device: indications and results.
Huggon IC; Tabatabaei AH; Qureshi SA; Baker EJ; Tynan M
Br Heart J; 1993 Jun; 69(6):544-50. PubMed ID: 8343324
[TBL] [Abstract][Full Text] [Related]
12. [Lung perfusion studies after percutaneous closure of patent ductus arteriosus using the Amplatzer Duct Occluder in children].
Parra-Bravo JR; Apolonio-Martínez A; Estrada-Loza Mde J; Beirana-Palencia LG; Ramírez-Portillo CI
Arch Cardiol Mex; 2015; 85(3):188-94. PubMed ID: 25700578
[TBL] [Abstract][Full Text] [Related]
13. [Percutaneous closure of patent ductus arteriosus with the Rashkind device].
Martins FM; de Menezes IC; Telo MC; dos Anjos RT
Rev Port Cardiol; 1994 Jun; 13(6):493-501, 476. PubMed ID: 7917394
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter occlusion of the patent ductus arteriosus with a single device technique: comparison between the Cook detachable coil and the Rashkind umbrella device.
Jaeggi ET; Fasnacht M; Arbenz U; Beghetti M; Bauersfeld U; Friedli B
Int J Cardiol; 2001 Jun; 79(1):71-6. PubMed ID: 11399343
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of the patent ductus arteriosus with new-generation devices: comparative data and follow-up results.
Donti A; Formigari R; Bonvicini M; Prandstraller D; Bronzetti G; Picchio FM
Ital Heart J; 2002 Feb; 3(2):122-7. PubMed ID: 11926010
[TBL] [Abstract][Full Text] [Related]
16. Is the new Occlutech duct occluder an appropriate device for transcatheter closure of patent ductus arteriosus?
Godart F; Houeijeh A; Domanski O; Guillaume MP; Brard M; Lucron H
Int J Cardiol; 2018 Jun; 261():54-57. PubMed ID: 29551254
[TBL] [Abstract][Full Text] [Related]
17. [Residual shunt after percutaneous occlusion of patent ductus arteriosus by Rashkind's device. Echographic aspects, outcome, prognostic factors and management].
Godart F; Rey C; Jarrar M; Francart C; Vaksmann G; Brevière GM
Arch Mal Coeur Vaiss; 1994 May; 87(5):567-72. PubMed ID: 7857177
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter closure of residual patent ductus arteriosus shunting after the Rashkind occluder device using single or multiple Gianturco coils.
Hijazi ZM; Geggel RL; al-Fadley F
Cathet Cardiovasc Diagn; 1995 Nov; 36(3):255-8. PubMed ID: 8542636
[TBL] [Abstract][Full Text] [Related]
19. Transarterial occlusion of patent ductus arteriosus with Gianturco coils in pediatric patients: a preliminary result in central Taiwan.
Lee ML; Chaou WT; Wang JK
Int J Cardiol; 1999 Apr; 69(1):57-63. PubMed ID: 10362373
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
